Bluechip Tex Ind (506981)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Book value of ₹137.36 provides some downside cushion; stock trades at only 1.2 times book.
• Latest quarterly sales of ₹54 Cr are far larger than the ₹34 Cr market cap, indicating a substantial asset base.
• Piotroski F-Score of 5/9 suggests moderate financial stability, not acute distress.
• Trading near 52-week high of ₹165, showing some market optimism or momentum.

Concerns

• Negative ROE of -3.48% and ROCE of -4.77% mean the business is destroying shareholder value.
• Sales are declining at -11.13%; latest quarter net profit is essentially zero, so there is no real earnings power.
• Zero dividend yield and undefined P/E mean investors receive no income or current earnings support.
• Promoter holding and debt/equity data are unavailable, raising transparency red flags for a small-cap.

AI Analysis

This is the kind of business I would pass on, but let me reason from the figures. Bluechip Tex is a small textile player with a market cap of just ₹34 crore. At ₹165, I am paying 1.2 times the book value of ₹137.36. That looks reasonable only if the business earns a decent return on those assets. It does not. Return on equity is -3.48% and return on capital employed is -4.77%. In other words, every rupee retained inside the business is earning negative returns. Graham would ask for earnings power; instead the latest quarter shows revenue of ₹54 crore but net profit of essentially zero. Sales are declining at -11.13% annually. The reported 90.91% profit growth is meaningless from a negative or tiny base. Textile manufacturing is a no-moat, commodity, cyclical business. Without pricing power, margins are at the mercy of raw material costs, export demand, and competition. The balance sheet appears stable enough—Piotroski score 5 out of 9—but I have no debt/equity or promoter holding data, which bothers me. A small company that does not disclose promoter holding is not a business I can sleep on. There is no dividend yield, so the shareholder gets nothing while waiting. The only real support is book value. If the assets are genuine and liquidation value is close to ₹137, the downside may be limited. But buying at ₹165 gives me no margin of safety for a business earning negative returns. This is an asset play, not a compounder. I would need the shares to trade below book, or proof of a durable turnaround—positive ROE, stabilised sales, honest disclosure—before putting any money here.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer